Corrigendum to “Transforming Growth Factor Beta1 being considered a novel biomarker in knee osteoarthritis” [Clin. Chim. Acta 472 (2017) 96–101]
- 4 March 2020
- journal article
- correction
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 505, 194
- https://doi.org/10.1016/j.cca.2020.02.027
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Transforming Growth Factor Beta1 being considered a novel biomarker in knee osteoarthritisClinica Chimica Acta; International Journal of Clinical Chemistry, 2017